GI Oncology
Conference Coverage
Dual targeting effective in HER2+ metastatic colorectal cancer
A combination of two drugs resulted in a 30% objective response rate in heavily pretreated patients with HER2-positive metastatic colorectal...
From the Journals
VIDEO: Occult cancers contribute to GI bleeding in anticoagulated patients
Significant morbidity, long hospital stays, and required transfusions result from treatment-related GI bleeding events.
From the Journals
Aggressive HCC in males traced to higher serotonin
Serotonin was shown to be crucial for activating hepatic stellate cells during HCC carcinogenesis.
Conference Coverage
Disease site determines QOL, pain in recurrent rectal cancer
SEATTLE – Posterior recurrence was associated with the worst quality of life and most severe pain.
Conference Coverage
Cardiovascular disease most common cause of death in CRC survivors
SEATTLE – Colorectal cancer is not the most likely cause of death in long-term CRC survivors.
From the Journals
Colorectal tumors: ESD passes long-term test
In superficial colorectal tumors, over a minimum of 5 years of follow-up, endoscopic submucosal dissection was effective and generally safe.
From the Journals
Barrett’s esophagus: Cancer risk is highest in first year after diagnosis
Catch Barrett’s esophagus early to prevent adenocarcinoma.
Feature
Colorectal cancer mortality highest in W.Va., lowest in Utah
More than 50,000 colorectal cancer deaths are expected in the United States for 2017, according to the American Cancer Society.
Case-Based Review
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
From the Journals
‘Strong evidence’ links obesity to cancers
A large umbrella review study of more than 200 meta-analyses finds that obesity is associated with a wide range of cancers.
From the Journals
Study supports multigene germline testing in colorectal cancer
About 10% of patients with colorectal cancer had at least one germline mutation known to increase the risk of cancer, according to results from a...